A cancer charity has said it is "angry and frustrated" that ministers and health officials have not approved the provision of ...

Jacob E. Berchuck, MD, highlights challenges in adopting liquid biopsy for PSMA expression and its potential to revolutionize precision medicine in prostate cancer.

Prostate cancer affects one in eight men during their lifetime, making it the second most common cancer among American males.

Scott Eggener, MD, gave a talk at the LUGPA annual meeting titled “Leveraging Cutting-Edge Technologies to Enhance Prostate Cancer Treatments.” ...

Dr. Chandler Park sat down for an interview with CURE® to discuss the biggest takeaway from the 2025 ASCO GU Symposium in ...

Men who experience acute adverse effects after radiation therapy for prostate cancer may be at higher risk for more serious ...

A cohort study of over 40,000 patients suggests that levels should be monitored for at least three months — longer than commonly practiced ...

A football fan from Dorchester is taking the fight to prostate cancer by walking more than 2 million steps in six months ...

What makes prostate cancer screening different than other cancer types? Get the facts. Test your knowledge of 5 factors of prostate cancer screening and shared decision-making. Shared decision-making ...

The first patient has been enrolled in the phase 3 PROSTATE-IQ trial being conducted in men with prostate cancer recurrence ...

Prostate cancer was the second leading cause of cancer deaths in North Carolina men in 2021; the bill aims to lower those rates.

Massey Comprehensive Cancer Center in Richmond is the first site in Virginia to offer a new non-surgical robotic ultrasound ...